STOCK TITAN

TransUnion (TRU) EVP awarded 11,776 restricted stock units in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TransUnion executive Alicia Brooke Zuiker reported an equity award. On February 27, 2026, she acquired 11,776 shares of common stock in the form of restricted stock units granted at a price of $0.00 per share. Following this award, her directly held stake increased to 57,455 shares.

The restricted stock units vest in stages, with 33% vesting on August 27, 2027, another 33% on August 27, 2028, and the remaining 34% on August 27, 2029, aligning the award with multi‑year retention and performance horizons.

Positive

  • None.

Negative

  • None.
Insider Zuiker Alicia Brooke
Role EVP, CHRO
Type Security Shares Price Value
Grant/Award Common Stock 11,776 $0.00 --
Holdings After Transaction: Common Stock — 57,455 shares (Direct)
Footnotes (1)
  1. [object Object]
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zuiker Alicia Brooke

(Last) (First) (Middle)
C/O TRANSUNION
555 WEST ADAMS STREET

(Street)
CHICAGO IL 60661

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TransUnion [ TRU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CHRO
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 A(1) 11,776 A $0 57,455 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of restricted stock units that vest ratably as follows: 33% on August 27, 2027; 33% on August 27, 2028; and 34% on August 27, 2029.
Remarks:
/s/ Rachel Mantz, by power of attorney 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TransUnion (TRU) report for Alicia Brooke Zuiker?

TransUnion reported that EVP and CHRO Alicia Brooke Zuiker received a grant of 11,776 restricted stock units on February 27, 2026. These units represent common stock and were awarded at $0.00 per share as equity-based compensation rather than a market purchase.

How do the newly granted TransUnion (TRU) restricted stock units vest?

The 11,776 restricted stock units vest ratably over three years. Specifically, 33% vest on August 27, 2027, another 33% on August 27, 2028, and the remaining 34% on August 27, 2029, creating a long-term incentive and retention schedule for the executive.

What is Alicia Brooke Zuiker’s TransUnion (TRU) share ownership after this Form 4?

After the reported award, Alicia Brooke Zuiker directly owns 57,455 shares of TransUnion common stock. This total reflects the impact of the February 27, 2026 restricted stock unit grant reported in the Form 4 insider filing for the company.

Was the TransUnion (TRU) insider transaction a market purchase or a stock grant?

The transaction was a stock grant, not a market purchase. Alicia Brooke Zuiker acquired 11,776 shares through a restricted stock unit award at $0.00 per share, categorized as a grant, award, or other acquisition rather than an open-market buy order.

What role does Alicia Brooke Zuiker hold at TransUnion (TRU) in this Form 4?

In this Form 4, Alicia Brooke Zuiker is identified as an officer of TransUnion, serving as Executive Vice President and Chief Human Resources Officer. The reported 11,776-share restricted stock unit grant represents part of her executive equity compensation package.

Does the TransUnion (TRU) Form 4 show any insider selling activity?

The Form 4 does not report any selling activity for this insider. It shows a single acquisition transaction, where Alicia Brooke Zuiker received 11,776 restricted stock units as a grant, increasing her direct ownership to 57,455 shares of TransUnion common stock.